The Administration of 4-Hexylresorcinol Accelerates Orthodontic Tooth Movement and Increases the Expression Level of Bone Turnover Markers in Ovariectomized Rats.
Animals
Biomarkers
/ blood
Cell Line, Tumor
Enzyme-Linked Immunosorbent Assay
Hexylresorcinol
/ administration & dosage
Humans
Male
Middle Aged
Osteocalcin
/ blood
Osteogenesis
/ drug effects
Osteopontin
/ blood
Ovariectomy
Rats, Sprague-Dawley
Tooth Movement Techniques
/ methods
Transforming Growth Factor beta1
/ blood
4-hexylresorcinol
animal model
bone morphogenic protein
nuclear factor kappa-B ligand
orthodontic
ovariectomy
tooth movement
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 Feb 2020
24 Feb 2020
Historique:
received:
04
02
2020
revised:
20
02
2020
accepted:
21
02
2020
entrez:
28
2
2020
pubmed:
28
2
2020
medline:
24
11
2020
Statut:
epublish
Résumé
Surgical methods for accelerating orthodontic tooth movement are limited by possible damage to the tooth root and patient discomfort. 4-Hexylresorcinol (4HR) has been shown to increase bone remodeling and may potentially facilitate tooth movement. This study investigated the (1) effect of 4HR administration on osteoblast-like cells and (2) effect of 4HR administration on tooth movement in ovariectomized rats. Saos-2 cells were treated with either 4HR or solvent (control). Protein expression levels were investigated 2, 8, and 24 h after treatment. Thirty ovariectomized Sprague-Dawley rats were divided into two experimental groups (A and B) and one control group. After installation of an orthodontic tooth movement device, groups A and B received subcutaneous weekly injections of 4HR (1.28 and 128 mg/kg). Micro-computerized tomography and histological analyses were performed after 2 weeks of tooth movement. The application of 4HR elevated expression of osteogenic markers in Saos-2 cells. Movement of the first molars was significantly greater in rats administered 4HR. Furthermore, the expression of bone morphogenic protein-2, receptor activator of nuclear factor kappa-B ligand, osteocalcin, and tartrate-resistant acid phosphatase were increased after 4HR administration. 4HR application demonstrated increased expression of osteogenic markers in Saos-2 cells and accelerated orthodontic tooth movement in rats.
Identifiants
pubmed: 32102282
pii: ijms21041526
doi: 10.3390/ijms21041526
pmc: PMC7073238
pii:
doi:
Substances chimiques
Biomarkers
0
Transforming Growth Factor beta1
0
Osteocalcin
104982-03-8
Osteopontin
106441-73-0
Hexylresorcinol
R9QTB5E82N
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Rural developement administration
ID : PJ01313902
Références
Curr Osteoporos Rep. 2016 Dec;14(6):292-309
pubmed: 27766484
Prog Orthod. 2018 Jun 25;19(1):18
pubmed: 29938297
Am J Orthod Dentofacial Orthop. 2009 Jan;135(1):16-26
pubmed: 19121496
Biochem Pharmacol. 2017 May 15;132:1-8
pubmed: 28189726
Maxillofac Plast Reconstr Surg. 2018 Dec 28;40(1):44
pubmed: 30613574
Am J Orthod Dentofacial Orthop. 2019 Nov;156(5):582-592
pubmed: 31677666
Eur Cell Mater. 2014 Oct 23;28:269-86
pubmed: 25340806
Osteoporos Int. 2009 Jun;20(6):843-51
pubmed: 19190842
Niger J Clin Pract. 2018 Mar;21(3):301-305
pubmed: 29519977
FEBS Open Bio. 2017 Dec 16;8(2):168-176
pubmed: 29435407
Mol Med Rep. 2019 Nov;20(5):4331-4339
pubmed: 31545488
Front Immunol. 2019 Mar 29;10:629
pubmed: 30984193
Am J Orthod Dentofacial Orthop. 2006 Apr;129(4):458-68
pubmed: 16627170
Prog Orthod. 2016 Dec;17(1):33
pubmed: 27696311
Biochem Biophys Res Commun. 2013 Mar 8;432(2):248-55
pubmed: 23402759
Maxillofac Plast Reconstr Surg. 2019 Nov 8;41(1):46
pubmed: 31763327
Am J Orthod Dentofacial Orthop. 2008 Apr;133(4):572-83
pubmed: 18405822
Sci Rep. 2019 Mar 4;9(1):3379
pubmed: 30833641
Ann N Y Acad Sci. 2018 Dec;1433(1):29-40
pubmed: 30091466
Bone. 1996 May;18(5):443-50
pubmed: 8739902
Int J Mol Sci. 2018 Oct 01;19(10):
pubmed: 30275408
Chem Rev. 1999 Jan 13;99(1):1-26
pubmed: 11848979
Am J Orthod Dentofacial Orthop. 2019 May;155(5):670-680
pubmed: 31053283
J Cell Biochem. 2013 May;114(5):975-84
pubmed: 23225263
Angle Orthod. 2012 Jul;82(4):637-44
pubmed: 22214389
J Rheumatol. 2002 May;29(5):990-8
pubmed: 12022363
J Korean Neurosurg Soc. 2012 Jun;51(6):323-7
pubmed: 22949959
Biomaterials. 2014 Oct;35(30):8576-84
pubmed: 25023393
Sci Rep. 2019 Mar 5;9(1):3448
pubmed: 30837602
J Oral Maxillofac Surg. 2011 Nov;69(11):e354-63
pubmed: 21821331
Arthritis Rheum. 1998 Feb;41(2):274-83
pubmed: 9485085
Endocrinology. 1973 Nov;93(5):1057-65
pubmed: 4778754
Int J Mol Sci. 2019 Oct 04;20(19):
pubmed: 31590328
Am J Orthod Dentofacial Orthop. 2011 Apr;139(4):e337-44
pubmed: 21457840
Orthod Craniofac Res. 2019 Feb;22(1):16-23
pubmed: 30449070
Angle Orthod. 1998 Apr;68(2):161-5
pubmed: 9564426
Ann Clin Biochem. 2018 May;55(3):308-327
pubmed: 29368538
Chirurgia (Bucur). 2017 Jul-Aug;112(4):413-417
pubmed: 28862117
Angle Orthod. 2011 Jul;81(4):570-7
pubmed: 21361777
Am J Orthod Dentofacial Orthop. 2007 Apr;131(4):448.e1-8
pubmed: 17418709
J Craniofac Surg. 2018 Oct;29(7):1983-1990
pubmed: 29561490
J Drugs Dermatol. 2016 Jul 1;15(7):863-8
pubmed: 27391637
Maxillofac Plast Reconstr Surg. 2018 Nov 22;40(1):34
pubmed: 30525010